SCHEMBL475134

SCHEMBL475134

CCN(C#N)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10953899 0.80
SCHEMBL5151350 0.79
SCHEMBL1862113 0.77
SCHEMBL7827896 0.77
SCHEMBL10953437 0.77 CA12 (0.39)
SCHEMBL1401018 0.76
Potassium Ion SCHEMBL9768589 0.75
SCHEMBL8253430 0.75 ZDHHC20 (0.42)
SCHEMBL3835809 0.74
SCHEMBL3361097 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103380466-B The method manufacturing transparency conducting layer and the transparency conducting layer manufactured by the method 印可得株式会社 2016-08-31 CN disclosed
CN-103665995-B Multi-functional coating solution composition INKTEC CO., LTD. (KR) 2016-05-04 CN disclosed
CN-103380466-A Method of manufacturing a transparent conductive layer and transparent conductive layer manufactured by same INKTEC CO LTD 2013-10-30 CN disclosed
EP-2411001-A1 P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN Merck Sharp & Dohme Corp. (US) 2012-02-01 EP disclosed
WO-2010111058-A1 P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN MERCK SHARP & DOHME CORP. (US) 2010-09-30 WO disclosed
WO-2010111060-A1 P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN MERCK SHARP & DOHME CORP. (US) 2010-09-30 WO disclosed